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ABSTRACT
The geographic disparity of multiple sclerosis has been noted in the literature for well
over a century. The frequency of the disease varies significantly both within countries
and in different parts of the world. The goal of this project is to give new insight
regarding the etiology of multiple sclerosis. Several theories regarding the etiology of the
disease have been reviewed, including a geographic theory, a nutritional theory, and a
genetic theory. Although the geographic and nutritional theories have been thoroughly
investigated by researchers, neither of them provides a conclusive explanation for the
etiology of the disease, and there are discrepancies with respect to both theories. The
purpose of this study is to reveal the discrepancies in the epigenetic theories regarding the
etiology of multiple sclerosis and to demonstrate the correlation of multiple sclerosis
prevalence and the migration and settlement history of Northern Europeans, thus
conferring the passage of a genetic susceptibility to the disease.
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CHAPTER I
INTRODUCTION

Multiple sclerosis is a chronic inflammatory disease that affects the central
nervous system (CNS). In patients with multiple sclerosis, myelin, the fatty tissue which
protects nerve fibers in the CNS, deteriorates leading to neurological problems and
disorders of the CNS. Patients with multiple sclerosis suffer from a variety of symptoms,
including visual problems, muscle weakness, difficulties with coordination and speech,
fatigue, cognitive impairment, problems with balance, and pain. Multiple sclerosis is a
debilitating disease which leads to impaired mobility and disability in most cases.
Currently, there are approximately 400,000 patients suffering from multiple
sclerosis in North America, and approximately 1.1 million people suffer from the disease
worldwide. The average age of onset is between 20 and 30 years. The disease rarely
occurs prior to age 10 or after 60 years of age. However, patients as young as 3 and as
old as 67 years of age have been diagnosed with the disease. Females are diagnosed 1.4
to 3.1 times more frequently than males (National Multiple Sclerosis Society 2007).
It appears that multiple sclerosis is a modern day disease, but there has been
mention of symptoms associated with the disease as far back as the 14th century. In 1947,
the skeleton of St. Lidwina of Schiedam, which is a suburb of Rotterdam, Holland, was
discovered during a reconstruction project. It appeared that Lidwina, who lived from
1380 to 1433 had a case of MS. The skeleton showed signs of muscular atrophy and
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paralysis of both legs. It was recorded that Lidwina suffered from difficulty walking and
a “hanging lip” which could possibly be indicative of facial paralysis. It was also
recorded that in the last 15 years of her life, Lidwina had large wounds on her body,
difficulty swallowing, blindness, and other pains (Murray 2005).
In 1979, Flemish neurologist Medaer analyzed Lidwina’s case and stated that it is
likely she suffered from MS, although MS is not the only explanation for her symptoms.
Other physicians have analyzed the case and believe that Lidwina’s case could also be
attributable to Lupus Erythematosus, which is another autoimmune disease associated
with skin lesions and disorders of CNS, including blindness. Although Lidwina’s case
cannot conclusively be described as MS, there are some other cases throughout history
that have also been ascribed as MS. It is interesting to note that all of the cases
mentioned herein have been located in northern Europe, where it is believed the disease
originated (Murray 2005 and Swiderski 1998).
The case of Sir Augustus Frederic D’Este, son of King George III of England, has
also been described as a likely case of MS. As a child he suffered from common
childhood infections and infestations. In 1827, D’Este exhibited the first serious health
malady indicative of MS. Then, at age 33, D’Este stated that he was experiencing
difficulty with vision, and he later experienced numbness of the lower back and thighs,
difficulties walking and incontinence. D’Este died at the age of 35, and at the age of his
death, he was losing his sense of hearing and was experiencing spasms so severe that he
could only walk with the help of a servant (Murray 2005 and Swiderski 1998).
Robert Carswell was a Scottish medical student in the 1830s. Carswell was a
medical artist who created a collection of drawings for his “Pathological Anatomy:
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Illustrations of the Elementary Forms of Disease” (1834-1838). Within the collection of
drawings, Carswell described lesions typical of MS based on two cases from Hospital of
La Pitie and the Hospital of La Charite. Both patients suffered from paralysis.
Furthermore, Jean Cruveilhier, a Parisian artist of the same time period as Carswell
created another collection of pathological illustrations which were published in
“Anatomie pathologique”. Along with his drawings, Cruveilhier provided a case history
and detailed clinical notes of patients including La Charite, Josephine Paget. The patient
died at the age of 38 on March 20, 1840. Cruveilhier performed an autopsy and
described what were likely to be MS lesions as “sclerose en plaques” (Swiderski 1998).
A French neurologist and student of Jean Cruveilhier, Jean-Martin Charcot,
established the infamous Charcot Clinic at the Salpêtrière Hospital for investigating
mental and neurological disorders. In 1862, Charcot and Edme Vulpian wrote a literature
review on “sclerose en plaques” citing mostly German sources. Charcot studied multiple
sclerosis intensely and gave lectures on the disease, which he continued to describe as
“sclerose en plaque” between 1868 and 1871. In 1892, Charcot published the most
comprehensive account of MS and it included accounts of mainly patients of northern
European descent (Swiderski 1998).
Multiple sclerosis is characterized by its epidemiological disparity in that it is
most frequently diagnosed in northern European nations and is rarely documented in nonCaucasian races. There are multiple theories on the etiology of multiple sclerosis,
including geographic, cultural and behavioral, and genetic suppositions, but to date, none
of these theories has been able to conclusively identify the etiology of the disease.
Approximately 15 to 20% of affected individuals have a family history of the disease;
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however, population studies have shown that there is no clear mode of inheritance of the
disease (Compston and Coles 2002, Sadovnick 1988). Thus, the etiology of multiple
sclerosis remains unknown. Studies have consistently shown that familial clustering
results from shared genetic factors rather than epigenetic factors, leading to the idea that
development of multiple sclerosis is primarily due to genetic predisposition.
The geographic disparity of multiple sclerosis has been noted in the literature for
well over a century (Charcot 1877). Although the prevalence can be difficult to reliably
assess from one geographical region to another (Poser 1994), it has become clear that the
frequency of the disease varies significantly both within countries and in different parts
of the world. The first epidemiological study by Davenport (1922) revealed how multiple
sclerosis seemed to affect individuals of Scandinavian and Finnish descent more than
individuals in other ethnic groups. Later, propositions that multiple sclerosis prevalence
was related to global latitude sparked a nature versus nurture controversy that still exists
today (Annegers 1991 and Betemps 1993).
When visually documented on a world map, the prevalence of multiple sclerosis
demonstrates striking features, such as the fact that according to lack of data from Africa
and physicians’ claims, the disease is almost non-existent in African nations and other
regions close to the equator, and the prevalence is much greater in nations of European
descent. For the purposes of this research project, Caucasian will be defined as white
individuals of northern European descent, and African Americans can be categorized as
black individuals whose ancestors originated in Africa but are currently living in America.
Furthermore, Asian Americans will be defined as people currently living in America
whose ancestors originated in Asia, including China, Japan, Taiwan, India, and Vietnam.
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Interestingly, the occurrence of multiple sclerosis is lower in African Americans and
Asian Americans than it is in Caucasian Americans, and it has been shown that there is a
higher percentage of African and Asian descendents who have developed multiple
sclerosis than the percentage of native Africans and Asians who have developed the
disease (Alter 1962, Oh 1969, and Rosati 2001). Thus, I hypothesize that since multiple
sclerosis occurs frequently in certain racial groups in certain geographic areas, a
comparison of global multiple sclerosis prevalence rates among nations and among racial
groups within the nations would help to determine whether the disease coincides with the
migration, settlement history, and admixture of the Scandinavians, who may carry a
susceptibility allele to the disease. Furthermore, it is through genetic admixture from the
Europeans to Africans throughout history, and specifically during the Slave Trade, that
the genetic susceptibility to multiple sclerosis has been passed to the African genome.
Remarkably, similar studies have been conducted to link susceptibility to cystic
fibrosis, hemochromatosis, and prostate cancer with the migration of northern Europeans.
It has been found that the genetic epidemiology of cystic fibrosis, hemochromatosis, and
prostate cancer has shown that inter-group breeding may lead to spreading of the
susceptibility alleles to other racial and ethnic groups (Sandblom et al. 2003, Higgins et al.
2005, Gilbert et al. 1995, and Acton et al. 2001). It appears then that the geographic
distribution of the varied frequencies of a disease reflects the history of migration,
settlement, and admixture of the population carrying the susceptibility, and that it is
possible for a genetic susceptibility to have been passed from one group to another over
several generations. Genetic epidemiology has been used in tracing the history of cystic
fibrosis, hemochromatosis, and prostate cancer to show that these diseases originated in
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northern Europe and have been passed to other races and ethnicities through genetic
admixture following inter-group breeding (Sandblom et al. 2003, Higgins et al. 2005,
Gilbert et al. 1995, and Acton et al. 2001).
A genetics-based etiology of multiple sclerosis is challenged by several seemingly
contradicting facts. First, the apparently random occurrence of multiple sclerosis in a
population may be due to low penetrance of the etiologic alleles. However, the
distribution within populations could also be explained by epigenetic mechanisms or by
gene-environment interaction. Second, although African Americans, or individuals who
have migrated to the United States from continental Africa, are susceptible to multiple
sclerosis, generally, there is a much lower prevalence of the disease in their nations of
origin in Africa, seemingly making it impossible for African Americans to have inherited
the susceptibility from their African ancestors. Third, multiple sclerosis incidence has
been continuously rising in recent years in nations that once exhibited extremely low
incidence, and there currently seems to be a surge in incidence. Given that the cause of
the trend is not clear, socioeconomic, dietary, and behavioral changes have been
pondered as contributing factors. Each of these concepts favor an epigenetic, rather than
a genetic etiology for multiple sclerosis.
Several epigenetic theories exist regarding the etiology of multiple sclerosis. The
primary epigenetic theories, or theories that do not imply that genetic inheritance is the
determining factor for developing multiple sclerosis, include a geographic theory and a
nutritional theory. The geographic theory entails that geographic location with respect to
proximity to the equator largely determines incidence of multiple sclerosis, while the
nutritional theory indicates that diet and vitamin D intake influence development of the
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disease. These epigenetic hypotheses for the etiology of multiple sclerosis have been
studied at length, yet neither of these theories can fully explain the etiology of the disease.
It is of utmost importance to determine the etiology of this debilitating disease,
especially for African Americans, who have proven to suffer from higher incidence of
cerebellar dysfunction and more rapid accumulation of disabilities due to the progression
of the disease (Marrie et al. 2006). Identification of genetic susceptibility to the disease
could lead to the establishment of a genomic marker for prediction and prevention of
multiple sclerosis, which would, in turn, be beneficial to public health. The purpose of
this study is to reveal the discrepancies in the epigenetic theories regarding the etiology
of multiple sclerosis and to demonstrate the association of multiple sclerosis prevalence
rates with the migration and settlement history of Northern Europeans, thus conferring
the passage of a genetic susceptibility to the disease.

CHAPTER II
REVIEW OF THE LITERATURE

There is an evident worldwide geographic distribution of multiple sclerosis which
can be observed when the occurrence of the disease is plotted on a world map. It
appears that the highest prevalence of the disease is found in the northernmost latitudes of
the northern hemisphere and the southernmost latitudes of the southern hemisphere
(Kurtzke 1977). This observation is based on the prevalence of the disease in
Scandinavia, the northern United States and Canada, as well as Australia and New
Zealand (Kurtzke 1977). There are currently several theories describing the
epidemiology of multiple sclerosis, including a nutritional theory, a geographic theory,
and a genetic theory, all of which are analyzed herein. Following the review of literature,
Table 1 identifies some of the key literature reviewed in this research.

Geography and nutrition in relation to development of multiple sclerosis
Epidemiological data indicates quite clearly that multiple sclerosis is a
geographically-related disease. The highest frequency of multiple sclerosis in the world
is exhibited in Europe between 65 degrees and 45 degrees north latitude, the northern
United States and southern Canada, and between 35 and 40 degrees south latitude in New
Zealand, and southern Australia (Figure 1).
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Figure 1. Nationwide prevalence rates in northern Europe, the U.S., Canada, and
Australia and New Zealand, along with detailed latitudinal proximity to the equator
According to Kurtzke (1977), these regions are surrounded by regions exhibiting medium
prevalence rates of multiple sclerosis in Europe to the north, east, and south; in the
southern United States; and in the northern and inland Australia. Latin America, Asia
and Africa exhibit fairly low prevalence of the disease. Kurtzke noted early on that
latitude is not a sufficient criterion for determining multiple sclerosis risk considering that
at 40 degrees north latitude, multiple sclerosis is high in America, medium in Europe, and
low in Asia. Kurtzke (1977) did, however, note that high and medium risk areas
appeared only in Europe or European colonies. Within the United States, multiple
sclerosis appears to be more common in Caucasians of northern European descent than in
African Americans, Asian Americans, and Native Americans.
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One of the hallmarks of multiple sclerosis remains its unequal distribution across
the globe. As previously noted, it is most common in populations of northern European
descent, and is diagnosed most often in Scandinavian nations, the United Kingdom, and
the northern United States and southern Canada (Compston 1997). Regions of high
incidence have been found in northwestern Sardinia (Sotgiu 2002 and Marrosu 2002) and
Sicily (Grimaldi 2001 and Nicoletti 2005). Several areas of abnormally high incidence of
multiple sclerosis have been found in Finland, as well. In these regions, there is an
approximately two-fold increased prevalence than the national average. Seinajoki in
southern Ostrobothnia, Finland, recently demonstrated an incidence of 12 cases per
10,000 people, which is the highest rate of multiple sclerosis reported anywhere in the
world (Sumelahti 2001).
Data from migration studies show that if the exposure to a higher risk
environment occurs during adolescence (before 15 years of age,) the migrant assumes the
higher risk of the environment. This concept is nicely illustrated in studies of native-born
South African Caucasian population with low incidence of the disease versus high
incidence of multiple sclerosis among Caucasian immigrants from Great Britain, where
the disease is much more prevalent (Kurtzke 1977). Epidemics of multiple sclerosis have
been reported and these provide further evidence of importance of environmental factors
in multiple sclerosis. The most notable “epidemic” was described on the Faroe Islands
after they were occupied by British troops in W.W.II. Similar increases in incidence of
the disease were seen on Shetland and Orkney Islands, in Iceland, and in Sardinia. A
specific point agent for these epidemics was never identified (Kurtzke 1977).
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Rosati et al. (1996) conducted a study in northern Sardinia, an island off the coast
of Italy, to investigate the incidence of multiple sclerosis in the Sardinian province of
Sassari. Results of previous studies in the area had indicated that multiple sclerosis
prevalence had increased more than two or three times than that of the standard increase
in prevalence in continental Italy during the time between 1980 and 1996. The purpose
of this study was to investigate the temporal trend of multiple sclerosis prevalence, which
is that as distance from the equator increases, so does prevalence of the disease. Rosati et
al. (1996) focused on the province of Sassari, which is located between latitudes 40º30’ N
and 41º N. The population of Sassari consists mostly of natives of Sardinia, and the
count of foreign inhabitants with regards to the study was negligible. Thus, the
researchers concluded that generalizations regarding the study population and the island
of Sardinia were warranted. The differences between human genomes in Italy and
Europe and Sardinia are 10 times higher than between non-Sardinian Italians and
Europeans, yielding a genetically homogenous population (Pugliatti 2001).
The crude overall prevalence rate in Sassari in 1997 was 144.4 per 100,000.
There were 686 total cases of multiple sclerosis, 492 women and 194 men. The
incidence rate was studied for the period between January 1, 1968 and December 31,
1997. The average annual incidence was found to be 4.9 per 100,000. The total
incidence rate had increased since the period of 1968-1972 from 2.0 per 100,000 to 6.8
per 100,000 from 1993-1997 population (Pugliatti 2001). Researchers concluded that the
observed multiple sclerosis prevalence rates were markedly higher than expected rates
would be in relation to the latitude of Sardinia. An increase in disease rate due to
increase in life expectancy was ruled out, as was an increase in immigration of people in
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high-risk age groups, and immigration of genetically high-risk individuals. Furthermore,
comparison to survey data collected by Granieri et al. (1996) from Ferrara, a province in
northern Italy revealed that prevalence of multiple sclerosis in Sassari was nearly three
times higher and that better diagnostic accuracy and improved epidemiological methods
could not fully account for the increased prevalence rates (Pugliatti 2001). Results from
this study indicated that the prevalence of multiple sclerosis in Sassari is among the
highest in the world (Kurtzke 1997). The high rate of multiple sclerosis in Sassari seems
to contradict the latitude gradient-based theory of multiple sclerosis, which suggests that
prevalence of multiple sclerosis is directly related to geographical latitudes, since
multiple sclerosis rates increased considerably in Sassari over the 30 year period of the
noted investigation, while they remained substantially unchanged in the similar
latitudinal region of Ferrara (Pugliatti 2001 and Granieri 1996). Instead, this research
indicates that multiple sclerosis is more prevalent in genetically susceptible populations.
Research also suggests that nutrition and diet, particularly those high in
consumption of animal fat and with low intake of fish products, may play a role in the
etiology of multiple sclerosis. Furthermore, it has also been suggested that vitamin D
intake has a protective effect on the risk of multiple sclerosis (Munger et al. 2000).
The theory regarding the protective effect of vitamin D intake on risk of
developing multiple sclerosis is directly related to the geographic theory of the disease,
which is that as distance from the equator decreases, so does prevalence of multiple
sclerosis. Exposure to sunlight, which increases as the distance from the equator
decreases, results in greater intake of vitamin D (Goldberg 1974, Acheson 1960,
Sutherland 1962, and Lebowitz 1967), and during the winter, high latitudinal regions
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experience low levels of ultraviolet (UV) sunlight, thus producing inadequate amounts of
vitamin D in individuals at latitudes greater than or equal to 42º (Webb 1988 and
Ladizesky 1995).
It has been shown that vitamin D dietary supplements given to mice have
prevented development of experimental autoimmune encephalomyelitis (EAE), which is
an animal model of multiple sclerosis (Cantorna 1996). Vitamin D is known to have
strong immunoregulatory effects (Provvedini 1983, Bhalla 1983, and Deluca 2001), and
studies have found that multiple sclerosis patients often exhibit insufficient Vitamin D
levels (Cosman 1994 and Nieves 1994). Researchers have also found that periods of low
vitamin D expression are accompanied by the occurrence of high lesion activity, meaning
that more demyelinization occurs simultaneously and after periods in which low levels of
vitamin D are recorded (Auer 2000 and Embry 2000).
Low vitamin D status has been implicated in the etiology of multiple sclerosis, as
well as other autoimmune diseases including rheumatoid arthritis, insulin-dependent
diabetes mellitus, and inflammatory bowel disease. The level of vitamin D intake
required to support optimal immune function remains unknown, but is likely to be at least
the same as that required for healthy bones. The vitamin D hormone (1,25-dihydroxy
vitamin D(3)) regulates T helper cell (Th1) and dendritic cell function while inducing
regulatory T-cell function. Cantorna and Mahon (2004) concluded that the result is a
decrease in the Th1-driven autoimmune response and decreased severity of symptoms of
autoimmune diseases such as multiple sclerosis. It has been noted that the diet is an
unreliable source of vitamin D; exposure to sunlight appears to be the most cost-effective
approach to obtaining adequate levels of vitamin D. It is believed that one reason
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prevalence rates of multiple sclerosis are so high in the northern hemisphere and in
regions far from the equator is that exposure to sunlight and thus, intake of vitamin D, is
considerably lower in these regions, especially during the winter time. Interestingly,
researchers have noted that symptoms of multiple sclerosis fluctuate in severity
seasonally (Goodkin 1989, Wuthrich 1970, Bamford 1983, Auer 2000).
In addition, it was determined in a German population that vitamin D status was
strongly correlated with multiple sclerosis lesion frequency (Embry et al 2000).
Additionally, Munger et al. (2000) studied vitamin D intake in more than 187,000 women
from two separate cohorts, one of which was followed for 10 years and the other followed
for 20 years. Overall, the risk of multiple sclerosis was 40% lower in women who
ingested more vitamin D (Munger et al. 2000), although sunlight was not accounted for
since the women in the study were ingesting vitamin D supplements. The researchers did
conclude, however, that vitamin D ingested as a part of regular diet did not affect risk of
developing multiple sclerosis (Munger et al. 2000). This research suggests that high
vitamin D intake, regardless of sunlight exposure, is associated with the reduced risk of
developing multiple sclerosis.
The nutritional aspect of multiple sclerosis was studied in relation to the
latitudinal theory of the disease in an epidemiologic investigation conducted by Esparza
et al. (1995). Researchers set out to determine the relationship between multiple sclerosis
mortality rates during the period 1983-1989 obtained for 36 countries and dietary fat and
latitude. The researchers conducted multiple regression analysis to determine the relation
ship between saturated fatty acids, animal fat, and animal minus fish fat. They found that
latitude was positively associated with multiple sclerosis mortality. The ratio of
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polyunsaturated fatty acids to saturated fatty acids and the ratio of unsaturated fatty acids
to saturated fatty acids were negatively correlated with multiple sclerosis mortality.
These results suggest that dietary fat intake and latitude are positively associated with
multiple sclerosis mortality (Esparza 1995).
Furthermore, recent epidemiological studies imply that unsaturated fatty acids
may have a positive effect on the course of the multiple sclerosis. Schwarz and Lewleing
(2005) conducted a meta-analysis of three clinical trials and found that there seemed to be
a nutritional benefit from linoleic acid associated with development of multiple sclerosis.
They also found that high intake of vitamin D is associated with lower prevalence rates of
multiple sclerosis. However, from their studies, the role of minerals, trace elements,
antioxidants, vitamins and fish oil remained unclear (Schwarz and Leweling 2005).
Furthermore, Ghadirian et al. (1998) studied the relationship between nutritional
factors and incidence of multiple sclerosis in Montreal, Canada from 1992 to 1995.
Researchers collected dietary information using a survey which was completed by 197
individuals. Dietary information was collected by employing a 164-item food frequency
questionnaire in a face-to-face interview. It was found that there was an inverse
association between high body mass index (BMI) and the risk of developing multiple
sclerosis. As BMI increased, risk for developing multiple sclerosis decreased, suggesting
that a fatty diet would be a protective factor against the disease. Furthermore, a positive
association was observed for animal fat intake and risk for developing multiple sclerosis,
and a significant protective effect was observed with other nutrients, including vegetable
protein, dietary fiber, cereal fiber, vitamin C, thiamin, riboflavin, calcium, and potassium.
These trends were similar in both males and females when examined separately. With
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respect to specific foods (as opposed to nutrients), a higher intake of fruit juices was
inversely associated with risk, suggesting that as ingestion of fruit juices increased,
multiple sclerosis incidences decreased. Finally, a protective effect was also observed
with cereal/breads intake for all cases combined, but for fish among women only, and
pork/hot dogs and sweets were positively associated with risk for developing the disease.
Overall, Ghiardian et al. concluded that their study did support the hypothesis that
a diet high in natural fruits, vegetables, and grains would have a protective effect on risk
for developing multiple sclerosis, while the evidence also suggested an increased risk of
the disease was associated with high intake levels of animal fat.
Yet another study to determine the relationship between nutrition and multiple
sclerosis was conducted by Tola et al. (1999). The results of this case-control study,
conducted in Italy, suggested that high intakes of bread, pasta, butter and lards, legume
soup, horse flesh, and caffeine-containing beverages before the age of 15 would result in
higher risk of developing multiple sclerosis. However, there was no association between
intakes of these items and development of the disease after puberty.
The possible relationship between diet and multiple sclerosis has not been
subjected to adequate study, and the protective role of nutrients with respect to the
disease need to undergo further analysis. However, the epidemiological data suggest an
association between multiple sclerosis and nutrition. It seems that populations that take
in a higher quantity of foods of animal origin (i.e., meat and dairy products) seem to be
the most affected by the disease. The role of saturated fatty acids in the progress of
myelinic damage has been implicated, and some case control studies indicate a timecause relationship between the intake of total calories and saturated fats and the incidence
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of multiple sclerosis. Meanwhile, other prospective studies failed to confirm this
hypothesis, yielding results that contradict the protective effect of a diet rich in antioxidant vitamins and polyunsaturated fatty acids. In patients with a progressive chronic
form of the disease, polyunsaturated fatty acids did not demonstrate any effect on the
progression of the invalidating lesions.
Nutritional interventions have been conducted in patients suffering from an acute
and remittent form of multiple sclerosis; these interventions have pointed to the
significant effect of treatment with polyunsaturated fatty acids in slowing down the
progression of myelinated lesions only in cases with a slight initial degree of disability or
no disability at all. However, the interventions seem to confirm the hypothesis of an
association between the magnitude of the disease and consumption of saturated fats and
show an improvement trend in patients treated with polyunsaturated fatty acids, although
the data are not statistically significant. It appears that the data regarding the nutritional
theory with respect to development of multiple sclerosis is inconclusive and ambiguous.

Genetics and the development of multiple sclerosis.
There are two types of evidence that suggest multiple sclerosis is a genetic disease.
The first type of evidence is derived from population studies. Multiple sclerosis is a
disease that affects primarily people of northern European heritage, and other ethnic
groups tend to be less likely to develop it. Secondly, evidence from family studies
indicates that individuals who have cases of multiple sclerosis in family members are
more likely to develop the disease themselves (Carton 1997). For instance, the average
person in the United States has an approximate chance of 1 in 750 of developing the
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disease; however, people who have relatives with multiple sclerosis have a higher risk of
developing the disease, ranging from 1 in 100 to 1 in 40 (Carton 1997). Furthermore,
researchers have shown that the identical twin of a patient with multiple sclerosis has a 1
in 3 chance of developing the disease (Mumford 1994, Willer 2003, Hansen 2005, and
Ristori 2006). Researchers have concluded from these twin and family studies that
genetic make-up is important for determining who may develop multiple sclerosis.
One of the hallmarks of multiple sclerosis is its unequal distribution across the
globe. It is most common in populations of northern European descent, and is diagnosed
most often in Scandinavian nations, the United Kingdom, and the northern United States
and southern Canada (Compston 1997). Regions of high prevalence have been found in
northwestern Sardinia (Sotgiu 2002 and Marrosu 2002) and Sicily (Grimaldi 2001 and
Nicoletti 2005). Several areas of abnormally high prevalence of multiple sclerosis have
been found in Finland, as well. In these regions, there is an approximately two-fold
increased prevalence than the national average (Panelius 1969, Wikstrom 1975,
Kinnunen 1983, and Sumelahti 2000). Seinajoki, in southern Ostrobothnia, Finland,
recently demonstrated an incidence of 12 cases per 10,000 people, which is the highest
rate of multiple sclerosis reported anywhere in the world (Sumelahti 2001). It has been
demonstrated that these areas are considered high-risk regions for multiple sclerosis.
Recently, haplotypes associated with multiple sclerosis have been identified. Tienari et al.
(2006) have suggested that such haplotypes could be used as molecular tools for tracing
common ancestry between patients in separate locations, thus providing clues to
historical origin of the disease. Furthermore, researchers have proposed that this
archealogical genetic approach would help to narrow the size of the haplotype shared

19
between groups allowing for the identification of etiological variants of multiple sclerosis
patients.
The evidence from family studies supporting a genetic susceptibility for multiple
sclerosis is compelling. Studies have been conducted on twin, half-sibling, and adoptee
populations of northern European descent, and the results of the studies suggest that
increased susceptibility to the disease is genetic (Ebers 1995, Willer 2003). In
monozygotic twins, there is a 20-30% increased risk for developing the disease, while the
risk is only 3-5% in dizygotic twins. Interestingly, in twin studies conducted in France
and Italy, the concordance rates for both monozygotic and dizygotic twins are reportedly
6-11% (French Research Group on MS 1992). The differing results from these two sets
of studies suggest that the role of genetics in inheriting multiple sclerosis is more
prominent in populations of northern European descent than in France and Italy. A
recent Canadian twin study revealed concordance rates of 34% versus 3.8% in
monozygotic versus dizygotic female-female pairs and 6.5% versus 11.4% in male-male
pairs (Willer 2003). The results in the Canadian twin study suggest that the role of
genetic factors is more powerful in women than in men.
The fact that the rate for identical twins both developing multiple sclerosis is
significantly less than 100 percent suggests that the disease is not entirely genetically
controlled. However, this could be due to the fact that some people with multiple
sclerosis lesions remain asymptomatic throughout their lives. This could also be due to
low penetrance of the susceptibility allele of multiple sclerosis.
Multiple sclerosis is considered to be a polygenic disease, meaning that multiple
genes contribute to the development of the disease. Thus far, no mutation leading to the
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disease has been identified. An association with the HLA-DRB1*1501-DQB1*0602DQA1*0102 haplotype is the most common finding in universal molecular genetics
studies on multiple sclerosis thus far. The association with HLA is not a new one.
Although this association has been known for over 30 years, it is still largely unknown
which of the three associations is the responsible variation, or if it is a combination of
several of the three variations that leads to the disease. Few non-HLA loci have been
found over the years, but the most common ones found in the literature are found on
chromosome 5p (Ebers 1996 and Kuokkanen 1996), 17q (Sawcer 1996, Saarela 2002,
and Barton 2004), and 19q13 (Barcellos 1997, D’Alfonso 2000, Pericak-Vance 2004, and
Reunanen 2002). The predisposing genes in these regions have yet to be identified.
Tienari et al. (2004) suggest that some of these genetic data are defined geographically,
and certain allelic associations appear restricted to southern Ostrobothnia. In a subregion analysis of Ostrobothnia, it was observed that the population area at high risk for
developing multiple sclerosis was relatively small, the Kyronjoki river region with a
population of approximately 100,000. The prevalence for multiple sclerosis in this region
was 210 per 100,000 in 1993 (Tienari 2004). Research indicates that the proportion of
patients with multiple sclerosis is higher in southern
Ostrobothnia than in neighboring regions or in southern
Finland (Figure 2) (Sumelahti 2003 and Tienari 2004).
Although Finland was not conquered by the
Vikings, there is archaeological evidence for a Viking

Figure 2. Prevalence of multiple sclerosis in Ostrobothnia compared to surrounding regions
(Figure adapted from Tienari 2004).
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influence in the southwestern high-risk area of Ostrobothnia (Lehtosalo-Hilander 1982);
this evidence shows a connection with the Kyronjoki river region,
and these observations demonstrate the Scandinavian influence in this region, which may
have been significant in leading to the high rate of occurrence in Finland today (Tienari et
al. 2004).
Myelin Basic Protein (MBP) and other haplotype signatures can be used as DNA
fingerprints to trace common ancestry between patients in different geographic locations.
It is assumed that MBP can provide clues to the historical origin of multiple sclerosis, as
well as be an approach to define a “superfamily” of multiple sclerosis patients with
common ancestry and common pathogenetic mechanisms (Tienari 2006). MBP would
help narrow the size of the shared haploytype identical-by-descent, and it would thus
make it easier to define etiological variants in patients with multiple sclerosis (Tienari
2006). Since the stretches of DNA identical-by-descent become smaller as the genetic
distance of patients increased, more focused high-density single nucleotide
polymorphism (SNP) and haplotype analyses as well as functional experiments at smaller
number of candidate sites are allowed. In other words, as the similarities between
genomes become greater between groups, it becomes easier to identify portions of the
genomes that may have mutations which could lead to inheritance of a certain disease. In
the case of multiple sclerosis, if a genetic “superfamily” could be identified by comparing
genomes of northern Europeans and African Americans, for instance, then this would
indicate that northern Europeans may have passed a genetic susceptibility to African
Americans if the same similarities between these two groups are not found in Africans
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alone. This type of analysis would also facilitate the search for the specific genes that
determine the etiology and risk for developing the disease.
Furthermore, genealogical evidence for a founder effect in multiple sclerosis has
also been reported in Overkalix in northern Sweden (Binzer 1994), in Lysvik parish in
western Sweden (Callander 2004), and in Sardinia (Marrosu 2002). A founder effect is
described as the effect of establishing a new population by a small number of individuals
who carry only a small portion of the original population’s genetic variation. The
resulting population could exhibith different genetic and phenotypic characteristics from
the original population from which it was derived, and this is what appears to have
happened in northern Sweden, Sardinia, and Ostrobothnia, Finland. Additionally, there
are clusters, or areas of increased incidence or prevalence of a disease which are
surrounded by regions where risk is not considered to be out of the ordinary, of multiple
sclerosis in continental Europe, in northern Croatia and western Hungary. In these areas,
some rural regions have reported prevalence rates approaching 200 cases per 100,000
population at risk (Guseo 2004). Inferences drawn from this data include probable
genetic isolation and possible Germanic ancestry, which is interesting since many
Scandinavians have Germanic ancestors (Tienari 2006).
The tools for SNP have advanced greatly with the Human Genome and HapMa
Projects. Thus far, more than a million SNPs have been analyzed through the HapMap
Project. Predisposing variants to multiple sclerosis will most reliably be caught by such
grand scale associations studies as the HapMap Project (Tienari 2006).
Genetic research on the inheritance of multiple sclerosis has determined that if a
person has multiple sclerosis, that person's first-degree relatives (i.e., parents, children
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and siblings) have a 1-3 percent risk of inheriting the disease (Carton 1997). Although no
specific gene for multiple sclerosis has been identified, several researchers have
concluded that people with multiple sclerosis inherit certain regions on individual
chromosomes more often than people without multiple sclerosis. Researchers are
investigating the human leukocyte antigen (HLA) on chromosome 6, since the HLA
patterns of multiple sclerosis patients appear to be different from those who do not have
multiple sclerosis. Development of multiple sclerosis is likely to be influenced by the
interactions of a number of genes, making it a polygenic disease. It is believed that each
of the genes ultimately “responsible” for the development of multiple sclerosis has only a
modest effect. Researchers continue to conduct studies to pinpoint specific genes that are
involved in the disease, to determine the function of those genes, and to learn how each
gene's interactions with other genes make an individual susceptible to multiple sclerosis.
In addition to leading to better ways to diagnose multiple sclerosis, such studies should
yield clues to the underlying causes of multiple sclerosis and, eventually, to better
treatments or a way to prevent the disease.
Researchers have noted that genes contributing to susceptibility to multiple
sclerosis are difficult to identify because they exert a relatively modest effect on disease
risk (Giovananni and Ebers 2007). The only unambiguous genetic association and
linkages identified thus far are with alleles of the human leukocyte antigen (HLA) class II
region, which is a part of the major histocompatibility complex (MHC). A large linkage
study conducted on 2692 individuals from 730 multiplex families of northern European
descent confirmed linkage to the MHC on chromosome 6p21 and suggested possible
linkage on chromosomes 17q23 and 5q33 (Sawcer 2005). Another large study of
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Canadian and Finnish families with multiple sclerosis genotyped 4203 individuals with a
high-density SNP panel spanning the genes encoding he MHC and flanking genomic
regions. These two studies indicate that MHC-associated susceptibility to multiple
sclerosis is determined by HLA class II alleles, their interactions, and possibly closely
neighboring variants, and that other regions in the genome are unlikely to contribute
much to disease susceptibility (Sawcer 2005, Lincoln 2005, Giovannani and Ebers 2007).
Multiple sclerosis is currently defined using a set of polythetic criteria, which by
definition cannot be 100% specific. Thus, even low rates of misdiagnosis could
drastically reduce the power of genomic studies to detect loci associated or linked with
the disease (Cardon 2003).
Family history remains to be the strongest indicator in multiple sclerosis diagnosis.
Segregation studies revealed that males with a history of multiple sclerosis in relatives of
the first and second orders are much more vulnerable to the same disease (Carton 1997).
In addition, histories of both paternal and maternal relatives have similar predicting
power, indicating an autosomal transmission of susceptibility (Carton 1997). Multiple
sclerosis exhibits a strong racial propensity. The disease is prevalent among Europeans
and African Americans, whereas it appears to be rare, sporadic, and random in Asia and
Africa. Normally, racial disparity is best explained by inheritance.
Recently, a whole-genome admixture scan found a candidate locus for multiple
sclerosis susceptibility. Admixture mapping is the process of scanning the human
genome for gene variants that affect risk for developing a disease. Studying genetic
markers whose frequencies differ between Europeans and Africans allows for the genome
of African or European ancestors to be more easily examined so that regions can be
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identified where individuals with specific diseases, such as multiple sclerosis, have an
abnormally high concentration of European or African genes (Rife 1954, Chakraborty
1988, Stephens 1994, Briscoe 1994, McKeigue 1997, and McKeigue 1998).
According to Smith et al (2004), there are two advantages to admixture scanning.
First, since African and European immigrants came into contact in North America, there
has been an average of only six generations of offspring from the two groups. Smith et al.
(2004) note that due to the few generations of populations since these groups were first
introduced in North America, there has been little recombination between chromosomes
of African and European ancestry in the history of African American populations (Smith
2004). Thus, a genome scan tagging all of either the African or the European
chromosomal segments in a group of African Americans requires only 1,000-3,000
markers, which is far fewer than the 300,000-1,000,000 markers required for a wholegenome haplotype scan (Carlson 2003). The second advantage of admixture mapping is
that it is much more effective at detecting disease risk variants that are of very low or
high frequency in Africans or Europeans but are highly differentiated in frequency across
populations, thus making it a perfect candidate for use in diseases with large racial
disparities. Multiple sclerosis is an excellent candidate for admixture mapping due to its
evident racial disparity between European Americans and African Americans (Kurtzke
1979). Therefore, a whole-genome admixture scan was conducted in African American
multiple sclerosis patients and compared with admixture scans for a group of cases and
controls. It was hypothesized that if genetic risk factors for multiple sclerosis explain its
epidemiology, they would be evident from the admixture scan as identifiable regions of
high European ancestry in African Americans with multiple sclerosis compared to the
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control group (Reich et 2005). As previously mentioned, genetic linkage scans have only
identified one risk haplotype for multiple sclerosis, which is at HLA on chromosome 6.
However, according to Reich et al. (2005), admixture mapping, which is considered to be
an association scan, is much more likely to identify the weak factors that explain the
disease risk. By estimating the extent of European ancestry in 605 African Americans
with multiple sclerosis and comparing their genome scans with those of the genome-wide
average for cases and controls, Reich et al. (2005) found that the strongest deviation from
the genome-wide average was on chromosome 1 near the centromere. Admixture
association was not detected anywhere else in the genome, and the researchers concluded
that an immediate priority of multiple sclerosis research should be placed on finemapping the chromosome 1 peak identified in this study to further investigate the
association between this locus and the risk of developing multiple sclerosis (Reich 2005).
Table 1. Key literature reviewed in Chapter II of the present study.
First
author

Year Study
Hypothesis /
Subject

Outcomes

Strengths /
Weaknesses

Kurtzke

1977

Geography in MS –
MS is an
environmental,
exogenous illness

Rosati

1996

Epidemiological
studies from Sardinia
since 1975 indicate 2
fold increased
prevalence of MS
than in surrounding
areas. Previous
populations too small
to draw conclusions.

High frequency of MS is found
between 65 and 45º north latitude
and southern Australia; Latin
America, Asia, and Africa have low
risk. All areas with high risk are in
Europe or European colonies, thus it
appears MS spread from western
Europe. MS is less common in
African Americans, Japanese
Americans, and Amerindians than in
Caucasians in the US
Frequency of MS was studied in
northwestern Sardinia in a population
of 270,000 and compared to other
Italian populations. Confirmed
higher frequency of MS among
Sardinians and attributed rates to
environmental and genetic factors.

Study is still used as basis
for geography and MS
information.
Study is old, published in
1997.
Findings contradict the
geographic theory of MS
because at 40º latitude,
MS was found to be high
in America, medium in
Europe, and low in Asia
Confirmed high rate of
MS in an otherwise low
frequency area close in
proximity to the equator.
Findings contradict the
geographic theory of MS.
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First
author

Year Study
Hypothesis /
Subject

Outcomes

Strengths /
Weaknesses

Munger

2000

Study of the
protective effect of
vitamin D on risk of
MS.

Results support a
protective effect of
vitamin D intake on risk
of developing MS.

Esparza

1995

Ecologic study of
relation between MS
mortality rates from
1983-1989 of 36
countries and dietary
fat and latitude.

Dietary vitamin D intake was
examined in 2 large cohorts (the
Nurses’ Health Study 1980-2000 and
1991-2001). Intake of vitamin D
supplements was inversely associated
with MS risk. No association was
found between vitamin D from food
and MS incidence.
Stepwise multiple regression analysis
determined that saturated fatty acids,
animal fat, animal minus fish fat, and
latitude correlated independently and
positively with MS mortality.

Ghadirian

1998

Nutrition and food
patterns, specifically
high intake of animal
fat and low intake of
fish play a role in
etiology of MS.

Sumelahti

2001

Investigation of
prevalence trends in
western and southern
Finland from 19831993.

Willer

2003

Tienari

2006

Longitudinal study of
MS concordance
rates in twins and
siblings.
Geographic and
genetic summary of
MS.

Reich

2005

Whole genome
admixture scan to
find a candidate
locus for MS
susceptibility.

Nutritional factors and MS studied in
197 incident cases and 202 controls
in Montreal between 1992-1995.
Dietary information was collected by
164-item food questionnaire and
interview. Inverse association was
observed between BMI and risk of
MS. Tall women showed greater risk
for MS. Protective effect observed
with vegetable protein, dietary fiber,
vitamin C, thiamin, riboflavin,
calcium, and potassium. High intake
of fruit juice inversely associated
with risk.
Age-adjusted and age-specific MS
prevalence rates were calculated. A
1.7-fold increase was found in 1993
when compared to 1983 prevalence
rates in Seinajoki, Finland.
Prevalence and incidence in this
region among the highest reported in
the world.
Concordance rates of 25.3% for
monozygotic and 5.4% for dizygotic
twins. 2-fold increase in risk to DZ
twins of non-twin siblings of twins.
Genetic studies identified haplotypes
associated with MS patients in
Finland suggesting a founder effect.
Haplotypes can be used to trace
common ancestry and geographic
origin of MS.
Admixture scan focused on 605
African American cases and 1,043
African American controls and
reported a locus on chromosome 1
significantly associated with MS.

Findings support
hypothesis liking dietary
fat intake and latitude to
MS mortality. Inuit diet
of mainly animal meat
was not taken into
consideration.
Results support protective
role for some components
commonly found in fruits,
vegetables, and grains,
and increased risk was
associated with high
animal food intake.
Native diets were not
taken into consideration.

Seinajoki, Finland region
linked with Scandinavian
migration. Highest
reported incidence and
prevalence indicates that
MS may have originated
in the area.
Demonstrates genetic and
familial facets of MS.
Demonstrates genetic
archeological approach to
define a “superfamily”
could implicate etiology
of MS.
Demonstrates ability to
find susceptibility allele
by examining “new”
populations with only
partial European ancestry.

CHAPTER III
METHODS AND PROCEDURES

In this study, published data from public records and multiple sclerosis prevalence
estimates from governmental and institutional sources were collected. In addition to
extracting data from the literature, related information on multiple sclerosis prevalence
was obtained from various web publications, including those of the World Health
Organization (WHO), the Centers for Disease Control and Prevention of the U.S.
Department of Health and Human Services (CDC), and the Multiple Sclerosis
International Federation (MSIF). From these databases, only the statistical information
covering the last 10 years was extracted for this analysis. The National Institutes of
Health website, PubMed, as well as internet search pages were used to collect data, and
searches were conducted using phrases including, but not limited to multiple sclerosis
and genetic etiology, multiple sclerosis and environment, multiple sclerosis and nutrition,
multiple sclerosis epidemiology, and distribution of multiple sclerosis.
Incidence is defined as the proportion of new cases in a population at risk for
developing multiple sclerosis divided by the size of the population at risk. Prevalence is
defined as a measure of the total number of cases in a population, rather than the rate of
occurrence of new cases, divided by the population at risk. In this project, primarily
prevalence data were collected and used for analysis; however, in some cases incidence
data was used. For instance, in First Nations Canadians, only incidence rates were found
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in the literature. In these cases, the incidence rates were described in lieu of prevalence
rates. When incidence data was used in this report, this fact is clearly stated so that
prevalence is not to be confused with incidence. Additionally, some of the data sources
reviewed in this project had differing incidence or prevalence rates for the same country.
In such cases, registry data obtained from MSIF were used in the analysis in lieu of
sample data. Registry information from MSIF was selected over sampling information
because in some cases, sampling measures are not necessarily indicative of the
prevalence of multiple sclerosis for an entire region. It appeared in all cases reviewed in
this project that registry data were more comprehensive than sample data.
An investigation was performed by collecting and reviewing relevant literature on
worldwide multiple sclerosis prevalence. Literature citing different explanations for the
etiology of multiple sclerosis, including geographic, nutritional, and genetic theories for
the etiology of the disease, were examined and summarized for this project. Some of the
literature reviewed that listed key findings and implications related to this project was
tabulated, and the table was inserted in Chapter II of this project.
The 2006 edition of the U.S. Central Intelligence Agency World Factbook was
used to obtain racial and ethnic information for this analysis. For the purposes of this
study, Caucasians are defined as white individuals with northern European ancestry;
African Americans are defined as black individuals living in America whose ancestors
originated in Africa; Asian Americans are defined as Americans whose ancestors
originated in China, India, Japan, Taiwan, and Vietnam. In addition to history textbooks
and archeological and anthropological literature, information on the migration, settlement,
and admixture history of different racial and ethnic groups was obtained from the World
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Factbook, from the free-content encyclopedia Wikipedia, from historical textbooks as
referenced, and from many other websites dealing with historical aspects of nations.
Prevalence rates obtained from the MSIF database and Rosati’s 2001 article from
Neurological Science entitled “The prevalence of multiple sclerosis in the world: an
update” were gathered for 77 nations, and the information was tabulated in order from
greatest prevalence to least prevalence (Table 2). Asterisks note that the prevalence rate
for the corresponding country was not obtained from MSIF, but rather from a literature
source, and that source is duly noted. Three charts were derived from the data listed in
Table 2. Data were separated into geographic areas as follows: Europe and Eastern
Europe, including Russia; the Middle East, the Far East, New Zealand, and Australia; and
North America, South America, and the Caribbean, and Figures 4, 5, and 6 demonstrate
these findings. Following tabulation of the data, prevalence of multiple sclerosis for each
nation was mapped manually on an editable outline map. Each nation was identified on a
world map (Figure 7) and on a European map (Figure 8), found on the editable map, and
then filled with a color corresponding to the prevalence rate as listed in the figure legend.
Editable outline maps in Mercator projection in the Powerpoint format were obtained
from Dr. Ruoxiang Wang, Assistant Professor of Urology at the Emory University
School of Medicine. The Red-Green-Blue (RGB) color scheme was used to construct a
continuous color spectrum to represent multiple sclerosis prevalence from ≤ 19 × 105
(green color: red, 0; green, 255; and blue, 0) to ≥ 150 × 105 (black color: red, 0; green, 0;
and blue, 0). The outline of each nation was filled with the color that represented the
prevalence of multiple sclerosis in that nation. Furthermore, in Figure 7, blue arrows
depict the Northern European migration routes, orange arrows depict Iberian, or Spanish
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and Portuguese, migration routes, and green arrows depict African migration routes. In
Figure 8, arrows were drawn depicting the Germanic Migration and Expansion from 750
BC to 600 AD (pink arrows), the Norsemen, or Viking, migration from 790 AD to 1090
AD (green arrows), and the Crusades from 1095 AD to 1272 AD (black arrows). Arrows
were drawn based on historical data found in textbooks and on Wikipedia.com
(Christiansen 2006, Encyclopedia Britannica 2007, Hoerder 2002, Wikipedia 2007a, b, c,
and d).

Data obtained from the Multiple Sclerosis International Federation
Results regarding the global occurrence of multiple sclerosis obtained from MSIF
and additional publications indicate that although incidence of multiple sclerosis
fluctuates on a yearly basis, the rate and trend for each nation remains relatively constant
when compared to international data. The MSIF was especially useful in providing
detailed international surveillance on multiple sclerosis prevalence rates. Specifically,
the European Map of Multiple Sclerosis Database provided multiple sclerosis prevalence
in 64 nations in the year 2006, a set of simplified but comprehensive statistical data
informative of multiple sclerosis prevalence on a global scale. To date, the database
consists of prevalence reports for 64 countries worldwide, but it is reported that another
32 will be added soon. Data from another 13 countries were added to this analysis using
information collected from the literature.
The information and data contained in the MSIF Atlas of Multiple Sclerosis web
application were collected using a questionnaire developed by MSIF, the WHO, and a
number of multiple sclerosis professionals. The data were chosen because the
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methodologies for obtaining the data were clearly outlined, well researched, and appeared
to be reliable based on the collection methods and follow-up conducted by researchers.
MSIF expresses the prevalence of multiple sclerosis in each nation as a rate of
cases per 100,000 population at risk. Upon collection of the MSIF questionnaires, which
were sent to 98 countries worldwide, the responsive data from 64 countries were
standardized and organized. MSIF compiled the responses, and took population data
from the WHO’s World Health Report 2000 to create an electronic database of global
prevalence rates of multiple sclerosis, which is now accessible by the public as the
European Map of Multiple Sclerosis Database at
http://www.europeanmapofms.org/emsp.aspx. Other sources for prevalence figures used
in this analysis are directly referenced herein.

CHAPTER IV
RESULTS
The hypothesis of the current proposal is that since multiple sclerosis occurs
frequently in certain racial and ethnic groups, and since most nations of the world consist
of a single racial group as the predominant racial group, a comparison of multiple
sclerosis prevalence rates among nations would help to determine whether the disease
coincides with migration, settlement, and admixture of an ethnic group that may carry
certain susceptibility alleles.
After conducting a comprehensive review of the literature related to the different
theories on the etiology of multiple sclerosis and compiling a table of global occurrence
of the disease, the results indicate that multiple sclerosis prevalence does indeed
correspond with the migration and settlement history of northern Europeans. The
migration and settlement history of the Scandinavians, along with information regarding
current global incidence or prevalence rates, depending on the information found for each
country, is detailed below.

European multiple sclerosis prevalence and migration history of the Scandinavians.
Due to the global disparity in multiple sclerosis distribution, the present research
project set out to investigate the existing multiple sclerosis prevalence data using a
geographic epidemiological approach. The overarching hypothesis of the present study is
that multiple sclerosis prevalence reflects a susceptibility genotype in individual
33
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populations, and the susceptibility allele originated in the population of the highest
prevalence and was distributed to other racial and ethnic groups through admixture. The
genetic epidemiology of cystic fibrosis, hemochromatosis, and prostate cancer has shown
that inter-group breeding may lead to spreading of the susceptibility alleles to other racial
and ethnic groups (Sandblom et al. 2003, Higgins et al. 2005, Gilbert et al. 1995, and
Acton et al. 2001). If this is truly the case, then the geographic distribution of the varied
frequencies of a disease reflects the history of migration, settlement, and admixture of the
population carrying the susceptibility.
In the present analysis, it was found that nations with the highest prevalence of
multiple sclerosis are located in northern Europe. Table 2 and Figures 7 and 8 illustrate
that other nations with comparable prevalence rates of multiple sclerosis are Canada (100
cases per 100,000 at risk), the United States of America (135 cases per 100,000 at risk),
Scotland (187 cases per 100,000 at risk), Australia (78 cases per 100,000 at risk), and
New Zealand (85 cases per 100,000 at risk), The residents of these nations share a
common origin; most of these nations’ residents are immigrants from northern Europe.
However, it should be noted that the indigenous Native Americans of North America, the
Aboriginals of Australia, and the Maoris of New Zealand, who inhabit similar
geographical environments as the descendents of northern Europe, are rarely diagnosed
with multiple sclerosis (Warren et al. 2007, Miller et al. 1986, Alter et al. 1971, Fawcett
and Skegg 1988, and Hornabrook 1971, National Multiple Sclerosis Society 2007). This
observation suggests that, at least in the U.S., Australia, and New Zealand, the high
prevalence of multiple sclerosis accompanied the northern European immigrants during
their migration, and this co-migration suggests that multiple sclerosis is almost certainly
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an inherited disease which originated in northern Europe. To demonstrate how this comigration may have occurred, it is important to map out the migration of the northern
Europeans and to investigate the potential relationship between their migration and the
current prevalence of multiple sclerosis.
Multiple sclerosis prevalence data for 77 European nations are available from
MSIF and other sources in the literature. A gradient distribution of multiple sclerosis
prevalence is a salient geographic epidemiological feature in Europe. With the highest
prevalence in northern Europe appearing in Norway, high rates of multiple sclerosis
prevalence spread along the coast of the northern Atlantic Ocean to all of the Western
European nations (Figure 7). Prevalence of multiple sclerosis declines gradually in
nations as they become more distant from Norway.
In addition to Norway, the other Scandinavian neighbors, Finland, Denmark, and
Sweden, each have high prevalence rates. In general, with Norway as the apex, high
multiple sclerosis prevalence radiates to the south and west to nations bordering the
North Atlantic Ocean. This radiation covers the west half of northern Europe, countries
including Sweden, Finland, Norway, Iceland, United Kingdom, and Ireland, all of
western Europe (i.e., Germany, the Netherlands, Belgium, Lithuania, France, Austria, and
Switzerland), and the west part of southern Europe (i.e., Italy, Spain, and Portugal).
Following this pattern, multiple sclerosis prevalence appears inversely proportional to the
respective country’s distance from Norway (Figure 8). On the other hand, the inland
portion of Europe, central and eastern European nations, as well as those in southeast
Europe, shows markedly reduced multiple sclerosis prevalence, even though the distance
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from Norway is essentially the same as the Western Europe nations (Figure 8), and the
geographic latitude of these nations is similar, as well.
This gradient of multiple sclerosis prevalence rates in northern and western
European nations is well recognized, and the relatively reduced multiple sclerosis
prevalence in the rest of Europe is also well known. To date, however, there has been no
satisfactory explanation for this phenomenon. Interestingly, European nations cohabit in
a relatively similar geographic environment with similar levels of exposure to sunlight,
similar climate, etc. Meanwhile northern and western Europeans enjoy the highest
standard of living together with affordable medical care. Yet, cause for the high multiple
sclerosis prevalence among these nations remains unknown.
As noted in the literature review, there are a number of theories regarding the
reasons for the gradient of multiple sclerosis prevalence rates. None of the theories
mentioned above can fully or conclusively explain the global distribution of multiple
sclerosis. The geographic, or latitudinal theory, was discounted with the examination of
multiple sclerosis incidence in Sassari, Sardinia. The latitudinal theory stated that as the
distance from the equator increased, so did prevalence of multiple sclerosis, presumably
due to the decrease in vitamin D intake. After investigating the incidence of multiple
sclerosis in Sassari as well as in other parts of Europe and Italy, researchers concluded
that the incidence of multiple sclerosis in Sassari was much higher than it would be
expected to be if the latitudinal theory fully explained the distribution of the disease
(Pugliatti 2001). Furthermore, Marrosu et al. (2002) examined the presence of familial
aggregation in Sardinian patients with multiple sclerosis by investigating the recurrence
risk in siblings of individuals affected with the disease. They evaluated factors
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influencing risk, such as patient and sibling sex, patient age at onset, sibling birth cohort,
and the presence of affected relatives other than siblings. To establish the contribution of
genetic factors to familial multiple sclerosis aggregation, the researchers verified the
presence of distant familial relationships among patients, tracing the extended pedigrees
of all multiple sclerosis patients born in the Sardinian village described by researchers as
“L.”, which, according to Marrosu et al. (2002) could be considered a “genetic drift” on a
microgeographic level. L.’s population showed little variation from the first census at
the end of 1600 to 2001 when the study was conducted, in the absence of substantial
admixture from nearby villages as reported from precise historical sources. Marrosu et al.
(2002) showed that the ratio between lifetime risk for a sibling of a patient with multiple
sclerosis divided by risk in the general population in Sardinians is similar to that reported
in populations of Scandinavian descent. Furthermore, it was found that that recurrence
risk in siblings of patients with multiple sclerosis varies widely according to the age at
onset of the disease and whether there are other affected family members. According to
the researchers, this finding suggests some degree of heterogeneity in the genetic
mechanisms underlying familial aggregation. However, pedigrees of patients from the
village of L., demonstrating that all affected subjects descended from three pairs of
ancestors, substantiated a “founder effect” as responsible for the disease in the village and
confirmed that Sardinian familial aggregation of the disease is genetic in nature (Marrosu
et al. 2002). It is important to note that these findings support a genetic etiology of the
disease.
Furthermore, the latitudinal theory is discounted with evidence showing that
Native Americans who currently live in the same latitudinal geographic area as other
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racial groups in the northwestern United States, do not exhibit the same high prevalence
of multiple sclerosis as the latter group (Warren 2007). Although most native
populations in North America have historically been nomadic, moving from one
geographic latitude region to another, and probably originated in Eurasia, to date, there is
no evidence in the literature that these groups have ever experienced moderate or high
levels of multiple sclerosis. This trend of natives exhibiting lower prevalence and
incidence rates of multiple sclerosis than migrants living in the same country can be seen
in almost any nation where northern Europeans have traveled and settled among natives
of the respective region (Kurtzke 1977).
Judging from Figure 7 it has become evident that elevated levels of multiple
sclerosis prevalence are found mostly in coastal nations, and since northern Europeans
conducted much of their exploratory traveling through maritime routes, it is not
surprising that rates of multiple sclerosis are higher near the coasts where explorers
would have migrated and settled. By examining the geographic distribution of multiple
sclerosis prevalence rates in Europe, data from the present study indicate that
susceptibility to multiple sclerosis is closely associated with the migration and settlement
history of northern Europeans and that the prevalence gradient in Europe results from
admixture of the Scandinavians with racial and ethnic groups in other parts of Europe.
Subsequently, the susceptibility allele for developing the disease was transmitted to other
races and ethnic groups throughout the migration and settlement history of the Europeans
by interracial admixture. This investigation indicates that there is indeed a genetic
susceptibility to multiple sclerosis, that the susceptibility originated in Scandinavia, and
that the alleles have been transmitted by gene flow to other races.
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The southward migration of the northern Europeans is well documented
(Wikipedia 2007a, b, c, d and MSN Encarta 2007). Three successive waves of southward
migration have been chronicled; the earliest of which was the Germanic Migration and
Expansion from 750 BC to 600 AD (Encyclopedia Britannica, Wikipedia 2007d). During
the Migration and Expansion, Germanic tribes in southern Scandinavia settled in
continental Europe and the British Isles located in the North Atlantic Ocean
(Encyclopedia Britannica 2007, Wikipedia 2007d).

This wave of migration was

followed by the Norsemen Migration from 790 AD to 1090 AD (MSN Encarta 2007).
Since the Vikings had such advanced technology and navigational skills, it was natural
for them to have traveled using maritime routes. They traveled mainly along the coast of
the North Atlantic Ocean, through the Straits of Gibraltar to the Mediterranean Sea
(Figure 8). In comparison, far fewer Scandinavians traveled into the inland area using
other means of transportation (Christiansen 2006, MSN Encarta 2007).
The third wave of migration, known as the Crusades from 1095 AD to 1272 AD,
consisted of large numbers of northwestern European men traveling to the Middle East
(Hoerder 2002, Wikipedia 2007b). It is possible that at the end of the two thousand years
of southward migration, settlement, and admixture, the original Scandinavian genetic
attributes had been transmitted along maritime routes to the British Isles and the
northwestern regions of continental Europe. Subsequently, genetic attributes were further
transmitted to other parts of Europe to form the northern European genetic gradient of
multiple sclerosis currently demonstrated. It is important to note that this gradient is
congruous with the current gradient in geographic distribution of multiple sclerosis
prevalence, suggesting that the susceptibility to multiple sclerosis is one of the genetic
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attributes that originated in southern Scandinavia, and was transmitted to other European
ethnic groups by admixture.
The geographic distribution of multiple sclerosis prevalence coincides with the
migration routes of the Scandinavians, and the gradient of the prevalence also reflects the
extent of Scandinavian settlements. Scotland and the United Kingdom, for example, are
populated mainly with Scandinavians and the prevalence rates of multiple sclerosis there
are reportedly among the highest in the world, making the prevalence rates in these two
regions comparable to the levels of multiple sclerosis in Scandinavia. Furthermore, it is
also known that Iceland was a frequent migration and settlement place for the
Scandinavians, and currently, the country exhibits substantial prevalence rates of multiple
sclerosis (Wikipedia 2007b and d).

Global multiple sclerosis and European migration, settlement, and admixture.
Due to the consideration that the gradient of multiple sclerosis prevalence in
Europe may be a result of genetic admixture of the northern Europeans with other races
and ethnicities, further analysis was performed in order to trace a potential link between
the Europeans and high multiple sclerosis prevalence rates in other parts of the world.
The high prevalence rates of multiple sclerosis in Canada, the United States of
America, Australia, and New Zealand could be due to migration and settlement by
northern Europeans and their descendents. These nations were once again settled by
northern Europeans in relatively recent historical times. Thus, it is possible that people
migrating from Europe may have carried the multiple sclerosis susceptibility allele to
Australia, New Zealand, and North America
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Europeans began to migrate to the New World, or the United States, on a large
scale in the 15th century, 700 years after the Scandinavians settled in different parts of
Europe (The Library of Congress 2007). Currently, most of the residents in the U.S. are
European migrants, their descendents, and the offspring of admixture between Europeans
and Native Indians. Furthermore, emigrants from European countries often settle in
regions where earlier emigrants from their native land have settled.
According to the data listed in Table 2, the national multiple sclerosis prevalence
rates in the United States and Canada parallel those in the European countries where
European Americans originated. Most of the European Americans in North America
originated in northwestern Europe where the prevalence of multiple sclerosis is high. It
is evident that both Canada and the United States of America have rates of multiple
sclerosis comparable to the rates in northwestern Europe (Table 2, Figure 7). On the
other hand, Central and South American countries, where the population majorities are
descendants of the admixture between native Indians and Spanish or Portuguese colonists,
exhibit much lower rates of the disease. Throughout history, the Spanish and Portuguese
settlers of Central and South America divided the region into two separate territories. It
is interesting to note that the South American countries (i.e., Peru, Mexico, Brazil, and
Argentina) settled by the Spanish and Portuguese have relatively low prevalence rates of
multiple sclerosis, as do Spain and Portugal when compared to their bordering nations.
The Caribbean countries have a complex history of colonization by several
different European powers. Both the Scandinavians and the western Europeans colonized
parts of the Caribbean at one point or another. In addition, European colonists brought
Africans into this area by participating in the Slave Trade. During the Slave Trade,
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admixture between the Europeans and the Africans was extensive and complete, meaning
that much of the time, Africans were not permitted to mate with people of their own race.
Furthermore, admixture was unidirectional in that it was the Caucasian men who were
mating with African women, rather than African men breeding with Caucasian women.
Thus, any genetic mixture between Africans and Caucasians would have been passed
from African mothers to their offspring. Many of the Caribbean countries now exhibit
relatively high multiple sclerosis prevalence rates, even though most of their current
inhabitants originated in Africa where multiple sclerosis is considered a rare disease. For
instance, Barbados reported prevalence of 26.3 cases per 100,000 at risk; Cuba reported
10 cases per 100,000; and Martinique reported 14 cases per 100,000.
Furthermore, the relatively high incidence of multiple sclerosis in African
Americans is an important issue affecting multiple sclerosis research. Since the rate of
multiple sclerosis in Africans is considerably lower than in African Americans, it is
evident that Africans are much less susceptible to the disease. Family history is a strong
risk factor for developing multiple sclerosis in African American populations indicating
that the disease may also be an inherited disease in this population (Multiple Sclerosis
Genetics Group 1998). Since African Americans could not have inherited multiple
sclerosis from their African ancestors who show low rates of the disease, it seems that
African Americans must have contracted the susceptibility allele from another source.
To identify that source, the epidemiology of multiple sclerosis in Africa was examined.
Unfortunately, nations in Africa have a limited life expectancy and the healthcare
systems in Africa are less advanced than in the rest of the world. Few African nations
reported multiple sclerosis prevalence rates to MSIF. Generally, researchers contend that
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Africa exhibits much lower levels of multiple sclerosis than Europe and the Americas
(Kurtzke 1977, Kurtzke 2000, Rosati 2000, Oksenberg 2004, Elian and Dean 1987, and
Modi 2001).
It is interesting to note that in addition to the much lower rate of multiple sclerosis
afflicting people in Africa, the distribution of the disease is greatly scattered. South
Africa exhibits a higher multiple sclerosis prevalence than Tunisia and Libya, which are
farther from the equator, but were settled by northern Europeans later than South Africa
(Wikipedia 2007c). It appears that multiple sclerosis prevalence rates reported in Africa
are not distributed uniformly; however, there have been few reported prevalence rates on
the continent. It is unknown whether this is because there are no cases to report, or if the
less than mediocre healthcare system is not capable of diagnosing the disease. The
highest prevalence of the disease in Africa has been reported in South Africa, where the
British influence is highest and where there are many English-speaking inhabitants;
meanwhile, no prevalence has been reported in inland Africa (Figure 7). In Libya, it
appears that the highest prevalence is demonstrated in the coastal region, whereas lower
prevalence has been reported from inland Libya. This could be indicative of the longer
settlement history along the coast since the area was settled through maritime travel.
Tunisia reported an prevalence rate of 10 cases per 100,000; Libya reported 9 cases per
100,000 in Kelibia, which borders the Mediterranean Sea, while Benghazi, further inland
reported prevalence of 6 per 100,000 (Attia Romdhane 1993, and Radhakrisnan 1985).
Additionally, 15 cases per 100,000 people at risk were reported in the Canary Islands
(Ben Hamida 1977). For many years, physicians working in the region claimed that there
were no cases of multiple sclerosis in sub-Saharan African nations (Poser 1996).
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However, Poser (1996) reported that there was evidence of several cases of multiple
sclerosis in black Africans in Senegal, although there were only 4 cases with autopsy
evidence; still, it appears that the prevalence was incredibly rare. South Africa, on the
other hand, has reported a relatively high prevalence of the disease (13 cases per 100,000
in English Speaking Caucasian south Africans, 4 cases per 100,000 in Afrikaansspeaking Caucasian Africans, and 3 cases per 100,000 in back South Africans), given that
its neighboring countries have reported that multiple sclerosis is virtually non-existent
within their borders (Dean 1967, Dean et al. 1994, and Kies 1989). Moreover, MSIF
(2006) reported that the prevalence rate was 32 per 100,000 at risk in South Africa. The
fact that multiple sclerosis appears to be more common in coastal regions in Africa, such
as Tunisia, the Canary Islands, and South Africa and less common in inland Africa based
on the lack of data coming out of the region and the observations by physicians that the
disease is virtually non-existent there, supports the premise that genetic admixture led to
the susceptibility of some, but not all Africans, given that admixture with Northern
Europeans was more likely to have occurred in the coastal nations due to their maritime
trade and migration routes (Poser 1996 and Rosati 2001).
The current research suggests that multiple sclerosis prevalence in these regions
of Africa is associated with the history of European colonization. The history of
European trade, migration, and settlement in Africa is well documented (Wikipedia
2007c). Five hundred years ago, Portuguese ships began exploring the Atlantic Coast.
The Dutch and the British began to settle in Africa, after the Portuguese journeys, in the
early 17th century along the same maritime route as the Portuguese (Wikipedia 2007c).
The Dutch and the British first settled in the coastal regions of western and southern
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Africa, and then moved inland. By the early 20th century most of Africa had become
colonies of western European nations. Historically, Europeans traveled along the coast of
the Indian Ocean much less frequently than they traveled along the Atlantic coast
(Wikipedia 2007c).
There appears to be an association between the migration and settlement history
of the Europeans and the geographic distribution of the elevated prevalence rates of
multiple sclerosis on the continent of Africa (Figure 7). This observation suggests that
Scandinavian admixture with other Europeans may have relayed a transmission of
genetic susceptibility to multiple sclerosis to northern and South Africans over time.
However, it is impossible to draw any conclusions about the incident rates in the interior
of Africa since no prevalence has been reported in this region.
While European admixture with Africans in Africa is regional and historically
transient, the European admixture with Africans in the Americas is historically thorough
and permanent. In the past in the Americas, gene flow between northern Europeans and
the Africans was mostly unidirectional from the former to the latter (Cavalli-Sforza et al.
1994 and Abe-Sandes 2004), and present day African Americans carry a substantial
amount of the European genome (Sans et al. 2002, Sans et al. 2000, and Chakraborty
1992). Thus it seems possible that the genetic susceptibility to multiple sclerosis could
have been transmitted from the Europeans to the African Americans.
According to the Mendelian theory of transmission of susceptibility alleles by
admixture, it would be possible to increase the susceptibility to a disease in the recipient
population, but the prevalence in the recipient population would not surpass that of the
donor population unless additional additive or synergistic factors existed. If African
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Americans inherited the susceptibility to multiple sclerosis from northern Europeans,
then they should have an elevated multiple sclerosis prevalence with respect to that of
native Africans. However, the prevalence of the disease in the African American
population would still be lower than, or at most equal to, the northern Europeans. With
this rationale, multiple sclerosis prevalence in African Americans was compared with that
of European Americans. It was found that African Americans develop multiple sclerosis
less frequently than European Americans (Bailey 1922, Alter 1962, Oh 1969, and
Kurtzke 1979). A recent study indicated that African Americans had a relative risk of
0.64 for developing the disease compared to their European American counterparts
(Wallin 2004). This observation suggests that African ancestry may indeed act as a
protective effect against multiple sclerosis, but it appears that the increased prevalence of
multiple sclerosis in African Americans compared to native Africans could be due to
admixture of the resistant African population with the susceptible European American
population.
Travelers from Scandinavia first explored the Western Hemisphere more than a
thousand years ago (The Library of Congress 2007). However, true settlement of North
America by Scandinavians began in the 17th and 18th centuries when wealthy
Scandinavians sought religious and political freedom in North America. By the 19th
century, the great migration of Scandinavians to the U.S. took place. Once in America,
most of the immigrants from Sweden, Norway, Denmark, and Finland chose to settle
primarily in the Midwest. They were drawn to the Midwest by the promise of open land,
and many of the emigrants were recruited by railroad companies and local governments
to settle remote parts of the country (The Library of Congress 2007). If the current
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theory of transmission of a susceptibility allele for multiple sclerosis is true, it would be
likely that the Midwest regions of America would have some of the highest rates of
multiple sclerosis today.
According to Wynn et al. (1990), Olmstead County, Minnesota currently exhibits
the highest prevalence of multiple sclerosis in the United States at 160 cases per 100,000.
Additionally, Galion city, Ohio, and Mower County, Minnesota have reported very high
prevalence rates at 112 and 100 cases per 100,000 population at risk, respectively
(Hopkins 1991 and Kranz 1983). These rates are considerably higher than rates reported
by other parts of the country. For instance, Los Angeles, California reported a prevalence
of 22 per 100,000 population at risk (Visscher 1977); King-Pierce Counties, Washington
reported 69 cases per 100,000 at risk (Visshcher 1977); 65 cases per 100,000 were
reported for Weld-Larimer Counties, Colorado (Nelson 1986); and 76 cases per 100,000
reported in Los Alamos County, New Mexico (Hoffman 1981). Interestingly, Key West,
Florida reported a prevalence rate of 110 cases per 100,000 population at risk in 1983
(Sheremata 1985). It should be noted that this area of Florida was primarily settled by
the Spanish, who exhibit elevated levels of multiple sclerosis, but not as elevated as the
Scandinavians.
It appears that the geographic distribution of multiple sclerosis in the United
States is definitely influenced by the varying genetic susceptibility to the disease between
racial and ethnic groups. In 1976, a national survey of multiple sclerosis reported
prevalence rates among Caucasians to be 49, while the same survey revealed that
prevalence among non-Caucasians was 26 (Baum 1986). In addition, a study of U.S.
Army veterans demonstrated that the risk of African Americans developing the disease
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was half that of Caucasian Americans, and the risk was even lower in Asians and
American Indians (Kurtzke 1979). Furthermore, a study conducted in Hawaii indicated
that the prevalence rate for multiple sclerosis in Caucasians was 26 per 100,000 at risk,
while the prevalence for Asians was 9 (Alter 1971).

Multiple sclerosis prevalence in the Middle East and migration history of the northern
Europeans.
Data from the Middle East regarding multiple sclerosis prevalence indicate that
the disease is high in some parts, and very low in others. Israel reported the highest
levels of the disease, but the data were difficult to interpret. In the northern region of
Israel, reports ranged from 29 to 38 cases per 100,000. Meanwhile in southern Israel,
near Jerusalem, rates ranged from 51 to 68 per 100,000. Kahana et al. (1994) examined
multiple sclerosis prevalence among native-born Israelis. It was found that the rate of
multiple sclerosis in native-born Israelis whose father had been born in Europe or
America was found to be as high or higher than that found in immigrants from Europe or
America. Furthermore, the incidence of multiple sclerosis in native-born Israelis of
European or American descent was significantly higher than the rate in native-born
Israelis of African or Asian descent. Once again, these data stress the genetic facets of
the disease and suggest that being of African or Asian descent may present a preventative
effect against developing multiple sclerosis (Kahana et al. 1994).
Other prevalence rates in the Middle East are fairly low. Iraq exhibited a
prevalence of 4, Saudi Arabia reported 10 cases per 100,000 at risk, Jordan reported 7
cases, and Kuwait reported 24 cases per 100,000 (Rosati 2001). The prevalence data

49
reported to MSIF by these countries were 6, 25, 7, and 10, respectively. One possible
explanation for the increased prevalence rates in Saudi Arabia and Kuwait could be that
since these are two of the largest oil exporters in the world, they have been influenced by
European and American migrants who have passed a genetic susceptibility to multiple
sclerosis to the original inhabitants in these regions.

Russian, Indian, and Asian multiple sclerosis prevalence and migration history of the
northern Europeans.
As previously mentioned, Scandinavian migration primarily followed a south and
westward route. Scandinavians did not travel inland toward Russia and Asia where
multiple sclerosis prevalence and incidence rates are relatively low (Wikipedia 2007b).
European Russia and
nations bordering
Russia on the western
side have reported
multiple sclerosis
prevalence rates
ranging from 16 in
Armenia to 50 in Latvia
(MSIF 2006).
Interestingly, in each
of the nations in this

Figure 3. Frequency of multiple sclerosis in European
Russia. Nat = prevalence in regional Natives (Rosati 2001).

region reported in Rosati’s review (2001), the multiple sclerosis prevalence recorded for
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natives was much lower than for Russians in the respective country (Figure 3). Rosati
(2001) explained that the differences in these data imply that genetic factors related to
development of the disease are very important. It was also pointed out that the risk of
multiple sclerosis among Russians born or living in the south portion of the former Soviet
Union was lower than that among Russians in the mother-country. This observation,
Rosati (2001) explained, confirms a complementary role of environmental factors
determining the geographic distribution of the disease.
Multiple sclerosis is considered to be a rare disease in India, China, Taiwan, and
Japan. Most of India did not report high levels multiple sclerosis prevalence. It has been
reported that although cases of multiple sclerosis have been recorded throughout India,
the northern region of India suffers from higher prevalence of the disease than the
southern portion. Moreover, northern India was settled by Indo-Europeans, while the
south part was settled by Tamil and Dravidian populations (Jain 1985). To date, Poona
and Bombay are the only regions of India with firmly reported incidence and prevalence
rates. Rosati (2001) reported that prevalence rates in Poona and Bombay were 58 and 28
per 100,000 population at risk, respectively. However, Singhal and Wadia (Bharucha
1988) reported that multiple sclerosis prevalence was only 1 per 100,000 among native
Indians in Bombay. The Parsi ethnic group in Bombay and Poona was the population
that exhibited the greater prevalence levels of the disease. According to (Wadia 1990),
the Parsis are of Persian origin and migrated to India in the 17th century. It is possible
that before their migration, Scandinavians had migrated to Persian regions and passed
their susceptibility to multiple sclerosis to the Parsis.
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In China, the prevalence of multiple sclerosis is very low. There are few studies
from China and Taiwan on the epidemiology of multiple sclerosis, but of the ones that do
exist, the disease appears to be very rare. In 1986, a door-to-door study was conducted in
Lang Cang Lu Hu Zu county of the Chinese Yunnan province, and it was estimated that
the prevalence of the disease was 2 cases per 100,000 population at risk (Hung 1982). In
Taiwan and Hong Kong, studies indicate that the rate is 1 per 100,000 (Hung 1982, Yu
1989, and Hou 1992).
Furthermore, multiple studies in Japan have indicated that the risk of developing
multiple sclerosis in native Japanese is between 2 and 4 cases per 100,000 population at
risk. However, it should be noted that there is a higher prevalence of the disease in
Japanese Americans. Japanese Americans in Hawaii exhibited an elevated prevalence of
9 cases per 100,000 population at risk (Alter 1971).
As previously noted, the Scandinavians did not travel inland to Russia, China, or
India as frequently as they traveled by sea (Wikipedia 2007b and d). Interestingly, the
highest prevalence of multiple sclerosis in these regions has been reported in the western
European nations bordering Russia as well as the northern and western regions of Italy
bordering the Indian Ocean where Scandinavians did travel, albeit infrequently. Again,
these observations support the idea that a genetic susceptibility was passed from
Scandinavians to other ethnic groups via genetic admixture between the groups at some
point throughout history.
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Native American, First Nations Canadian, Aboriginal Australian, and New Zealand
Maori multiple sclerosis prevalence rates and migration history of the northern
Europeans.
Current explanations for the apparent ethnic disparity in multiple sclerosis and
prevalence among native and aboriginal groups in Australia, North America and New
Zealand include differences in socioeconomic factors and differences in environmental
factors. For instance, the Alaskan Inuit and New Zealand Maori are less likely to present
with multiple sclerosis symptoms to medical practitioners since they often do not seek
professional medical attention (Chan 1977, Miller 1986, and Acers 1994). Also, these
groups of people might be less likely to live in areas with exposure to environmental
triggers of multiple sclerosis. Australian aboriginals, for example, live close to the
equator, and according to the environmental geographic theory regarding development of
multiple sclerosis, would be unlikely to develop the disease. However, yet another
plausible explanation is that differential susceptibility to multiple sclerosis between these
native groups and European groups is partially conferred by variation in genetic
inheritance (Miller 1986).
Multiple sclerosis prevalence is relatively low in Australia compared to northern
European nations. Rates from 11 in Northern Queensland, which is close to the equator,
to 33 in Adelaide, which is in southern Australia, have been reported (Compston 1998).
Interestingly, the British Royal Navy settled Australia’s eastern coast in the late 1700s
(Wikipedia 2007a). Moreover, they settled in the southern Australia region, which is
now the capital, Sydney, and this is the region of Australia which currently exhibits the
highest prevalence and incidence of multiple sclerosis. Additionally, New Zealand was
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first visited by British Captain James Cook in 1779, and the island, along with Tasmania,
was settled in the 18th century by people from Great Britain, who had Scandinavian
ancestry (Wikipedia 2007a). New Zealand currently exhibits a multiple sclerosis
prevalence of 69 cases per 100,000 population at risk (Compston 1998, Skegg 1987).
Furthermore, there appears to be a gradient of distribution of multiple sclerosis in New
Zealand, with higher prevalence rates exhibited in the south, and lower prevalence rates
in the north. This gradient has previously been correlated to the higher proportion of
people of Scottish ancestry in the south (Skegg 1987), thus implicating that genetic
susceptibility to the disease has been passed to inhabitants in southern New Zealand
throughout history.
Despite the relatively high prevalence rates exhibited by people of northern
European ancestry in Australia, New Zealand, and North America, multiple sclerosis is
considered to be a rare disease in aboriginal Australians, the Maoris in New Zealand, and
the Native Americans in North America. Warren et al. (2007) analyzed data from
government health databases and described the incidence of multiple sclerosis among
First Nations aboriginal people in the province of Alberta, Canada. The researchers then
compared the incidence in this group to the general population from 1994 to 2002. It was
found that the general population rates were consistently higher than First Nations rates,
and prevalence was essentially stable over the same period of time. First Nations people
exhibited an incidence of 7.6 per 100,000, while the incidence of multiple sclerosis was
20.6 per 100,000 for Canadians of northern European descent in 2002. From 2000-2002
for First Nations the incidence was 12.7 for females and 7.6 for males, with a female-tomale ratio of 1.7:1. In addition, during the same time period, the incidence of multiple
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sclerosis in the general population of Alberta, Canada was 32.2 for females and 12.7 for
males, with a female-to-male ratio of 2.5:1. The high incidence rates are consistent with
high prevalence rates reported for both groups in 2002: 99.9 per 100,000 for First Nations
and 335.0 per 100,000 for the general population (Warren 2007). Warren et al. (2007)
found that the incidence of multiple sclerosis was, indeed, significantly lower in First
Nations people than in the general population of Alberta; however, it was also found that
the incidence rates in First Nations people would not be considered “rare” by worldwide
standards (Warren et al. 2007).
Furthermore, according to previous research studies, the incidence and prevalence
of multiple sclerosis in the New Zealand Maori, a group of aboriginal people in New
Zealand, have been reported to be substantially lower than in the European population.
(Chancellor

et al. 2003; Fawcett and Skegg 1988; Hornabrook 1971; and Miller et al.

1986). Remarkably, it has also been found that Caucasian individuals living in New
Zealand who have Maori ancestry, appear to exhibit lower susceptibility to the disease
(Skegg 1987).
Finally, according to the National Multiple Sclerosis Society, multiple sclerosis is
virtually nonexistent in Inuits (Chan 1977, Acers 1994, Poser 1994, and National
Multiple Sclerosis Society 2007). It has previously been hypothesized that these groups
do not develop multiple sclerosis due to their diet of primarily animal meat and fish
(Chan 1977).

However, this idea completely contradicts the popular belief that diets

low in saturated fat with no red meat and no high fat dairy products are the diets that
prevent development of multiple sclerosis as reported previously in the review of
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literature (Esparza 1995, Ghadirian 1998, Munger 2000, and Schwarz and Leweling
2005).
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Table 2. Global occurrence of multiple sclerosis listed from greatest to least
prevalence (Data obtained from MSIF 2006 unless noted with an asterisk.)
Country
Occurrence
Country
of MS per
100,000
**Scotland
187
Turkey
Germany
149
Georgia
United States of America
135
Yugoslavia
Norway
132
South Africa
Czech Republic
130
Romania
Denmark
122
Barbados
Poland
120
United Arab Emirates
**Sweden
112
Malta
Switzerland
110
**Saudi Arabia
United Kingdom
110
Uruguay
Iceland
110
Turkmenistan
Finland
100
Brazil
Netherlands
100
Argentina
Ireland
100
Slovakia
Luxembourg
100
**Macedonia
Austria
100
Armenia
Canada
100
Tunisia
Italy
90
**Martinique
Belgium
88
Bahrain
Croatia
87.5
Chile
New Zealand
85
**Kyrgyzstan
**Slovenia
83
**Uzbekistan
France
80
**Albania
Bosnia and Herzegovina
80
Cuba
Hungary
79
**Kuwait
Greece
78
Mexico
Australia
78
Libyan Arab Jamahiriya
**Tasmania
68
Japan
Spain
59
**Jordan
Latvia
50
Iraq
Portugal
50
Paraguay
Serbia & Montenegro
50
Colombia
**Israel
50
Costa Rica
Belarus
47
Peru
Bulgaria
44.5
India
Cyprus
43
Guatemala
Russian Federation
40
China
Estonia
39
Viet Nam
Lithuania
36
Hong Kong
** Data obtained from Rosati et al. 2001

Occurrence of
MS per
100,000
34
33
32
32
31
26.3
26
25
25
22
20
18
18
17.5
16
16
15
14
13
11.7
11
11
10
10
10
9
9
8
7
6
5.7
5
4.25
4
3
2.5
2
2
0.77
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Figure 4. Occurrence of multiple sclerosis in Europe and Eastern Europe, including Russia

Occurrence of MS in Europe and Russia
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Figure 5. Occurrence of multiple sclerosis in the Middle East, the Far East, New Zealand, and Australia
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Figure 6. Occurrence of multiple sclerosis in North America, South America, and the Caribbean

Occurrence of MS in North America, South America, and the Caribbean
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Figure 7. Global occurrence of multiple sclerosis and migration routes of Northern Europeans, Iberians, and Africans
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Figure 8. Occurrence of multiple sclerosis in Europe and Germanic, Viking, and Crusade migration route

CHAPTER V
DISCUSSION AND CONCLUSION

The goal of this project was to give new insight regarding the etiology of multiple
sclerosis. Several theories regarding the etiology of the disease have been reviewed,
including a geographic theory, a nutritional theory, and a genetic theory. Although the
geographic and nutritional theories have been thoroughly investigated by researchers,
neither of them provides a conclusive explanation for the etiology of the disease, and
there are discrepancies with respect to both theories.
It has been suggested that nutrition and diet, particularly high consumption of
animal fat and low intake of fish products, may play a role in the etiology of multiple
sclerosis. Judging from the literature review, this theory regarding the etiology of the
disease is ambiguous and inconclusive. There are contradictory findings regarding this
theory. Results suggesting that diets high in fat intake and consisting of red meat
increase the risk of developing multiple sclerosis are easily contradicted when we look at
the distribution of the disease. For instance, the Inuits’ diet of almost entirely red meat
and few vegetables does not coincide with evidence suggesting this is a risky diet
considering that multiple sclerosis is virtually non-existent within this population (Chan
1977 and Poser 1994).
Furthermore, the geographic, or latitudinal theory, which states that as the
distance from the equator increases, so does the incidence and prevalence of multiple
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sclerosis, was discounted with the examination of multiple sclerosis incidence in Sassari,
Sardinia. Researchers found that the incidence of multiple sclerosis in Sassari was
much higher to be expected if the latitudinal theory fully explained the distribution of the
disease when they compared local data with surrounding incidence levels in Europe and
Italy (Rosati 2001).
Additionally, the latitudinal theory is contradicted by evidence showing that
Native Americans, who live in the same latitudinal geographic area as northwestern
United States residents, do not exhibit the same high prevalence of multiple sclerosis as
the latter group (Multiple Sclerosis Research Group 1998, Warren et al. 2006). This
trend can be seen in almost any nation where northern Europeans have traveled and
settled among natives of the respective region. Furthermore, Kurtzke (1977)
demonstrated that latitude is not a sufficient criterion for determining multiple sclerosis
risk. It was shown that at 40 degrees north latitude, multiple sclerosis is high in America,
medium in Europe, and low in Asia. This observation is completely inconsistent with the
theory that multiple sclerosis incidence and prevalence increase as does distance from the
equator increase. It was, however, noted that high and medium risk areas appeared only
in Europe or European colonies.
Since multiple sclerosis occurs frequently in certain racial and ethnic groups, and
since most nations of the world consist of a single ethnic group as population majority, a
comparison of multiple sclerosis prevalence rates among nations should help to
determine whether high prevalence of the disease concurs with migration, settlement, and
admixture of an ethnic group that may carry certain susceptibility alleles. Under this
premise, the current project examined the geographic distribution of prevalence of
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multiple sclerosis and found that susceptibility to the disease is closely associated with
the migration and settlement history of northern Europeans. The gradient of disease
prevalence which is demonstrated in Figure 2 results from the admixture of Scandinavian
genes with ethnic groups in other parts of Europe throughout history. Following
admixture of the Scandinavian genome, susceptibility to multiple sclerosis was
transmitted to other races and ethnic groups throughout the migration and settlement
history of the Europeans by interracial admixture. The current thesis research indicates
that there is, indeed, a genetic susceptibility to multiple sclerosis which originated in
Scandinavia, and the susceptibility alleles have been transmitted to other races by gene
flow.
Mendelian diseases exhibit distinct inheritance patterns when passed from one
generation to another. They are usually easily identified by a specific gene that
segregates cleanly with the disease in affected families. Multiple sclerosis has not been
identified as a disease with clean Mendelian pedigree, and to date, no one gene has been
determined to be the cause of multiple sclerosis. Since multiple sclerosis cannot be fully
described by a Mendelian genetic inheritance, a variety of genetic studies have been
conducted to determine the genetic factors associated with the disease. To date, more
than 55 full and partial genome screens and follow-up studies have been conducted for
multiple sclerosis, and hundreds of genetic markers have been examined in these studies
producing a number of interesting loci related to the disease. However, none of these loci
have been shown to exhibit a particularly strong effect.
These data suggest that although there is not a particular Mendelian effect as far
as genetics are concerned, it is likely that multiple sclerosis is a multi-gene disease and
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that it is a disease with etiologic alleles of low penetrance. The low penetrance of a
genotype would lead to an age-dependent and rare presentation of the corresponding trait,
making it difficult to distinguish the genotype from external influences. Conversely,
Mendelian inheritance makes the trait unique in certain ethnic groups, which may be
transmitted to other groups by admixture. Since the genotype may have not yet been
equally spread among different races and ethnic groups, the corresponding trait should be
traceable, based on the migration, settlement, and admixture history of the original carrier.
In addition, histories of both paternal and maternal relatives have similar.
predicting power, indicating an autosomal transmission of susceptibility (Schaid et al.
1998 and Valeri et al. 2003). Multiple sclerosis is prevalent among Europeans,
Americans of northern European descent, and African Americans, whereas it appears to
be a rare occurrence in Asia and Africa (Rosati 2001). The racial disparity is best
explained by inheritance. Lastly, a candidate locus for multiple sclerosis susceptibility
has recently been found in patients in the European, European American, and African
American populations (Reich et al. 2005). In this case, it is clear that these unique
genetic markers were transmitted by admixture between the two archeologically and
anthropologically distinctive racial groups. Theoretically, these facts demonstrate that
multiple sclerosis is an inherited disease.
Presently, there is minimal research regarding the significance of interracial
admixture as it relates to passing susceptibility alleles from one racial group to another.
However, it is well understood that genetic susceptibility to a specific disease will be
transmitted among groups when the groups in question are geographically adjacent to one
another. Susceptibility to cystic fibrosis, prostate cancer, and hemochromatosis are all
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diseases that have been linked to northern European origination (Higgins et al. 2005,
Gilbert et al. 1995, and Sandblom et al. 2003). It has been found that the susceptibility
alleles of each of these diseases exist in racial and ethnic groups other than Caucasian
northern Europeans. The transmission of these alleles was due to inter-group admixture
(Higgins et al. 2005, Gilbert et al. 1995, and Sandblom et al. 2003).
Although the association between multiple sclerosis susceptibility and the
migration history of the Europeans has been previously reported, the key conclusion of
this study is that the high susceptibility in other racial and ethnic groups is due to
admixture with Europeans. There are few studies on the significance of interracial
admixture with respect to the spreading of genetic susceptibilities, but previous research
supports the idea that a genetic susceptibility will be transmitted from one group to
another as long as these groups are geographically adjacent to one another. For instance,
northern Europeans are uniquely predisposed to diseases such as cystic fibrosis and
idiopathic hemochromatosis. The respective northern European alleles are found in other
racial and ethnic groups due to inter-group admixture (Higgins et al. 2005, Gilbert et al.
1995, Sandblom et al. 2003, Parra et al. 1998, Rybicki et al. 2002, Cabello et al. 1999,
and Acton 2001).
The geographic distribution of the ∆F508 cystic fibrosis allele is a typical
example of the results of European admixture. The mutation for cystic fibrosis originated
in northwestern Europe, and it has been observed that the gradient distribution of its
frequency in Europe is similar to that of multiple sclerosis prevalence. Furthermore, the
∆F508 allele has been transmitted to African Americans and Latin Americans through
admixture in other parts of the world. The similarity in their geographic distributions
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strongly suggests that, similar to cystic fibrosis, multiple sclerosis is transmitted by
susceptibility alleles.
Additionally, in the case of insulin-dependent diabetes mellitus (IDDM), genetic
epidemiology has indicated that gene flow from Europeans is responsible for the
increased frequency and the early onset of IDDM among young African Americans
(Pereira et al. 2001 and Vizzi et al. 2005). In addition, a recent genome linkage scan
investigation defined two alleles at chromosome 8q24 that are associated with an
increased prostate cancer incidence both in Northern Europeans and in African
Americans, and the alleles seem to be of European ancestry (Pakkanen et al. 2007,
Freedman et al. 2006, and Amundadottir et al. 2006). These alleles are not frequently
found in native Africans and other racial and ethnic groups. It appears that these alleles
are located in the chromosomes of northern Europeans, and that African American
prostate cancer patients have inherited them through admixture with Europeans.
The results of this project demonstrate an alternative approach to the
identification of the susceptibility alleles. Considering that admixture may transmit
chromosomes from one race to another, probably in a random fashion, multiple sclerosis
patients of non-European origin should share common European chromosomal
components that harbor the susceptibility alleles (Reich et al. 2005). These same
components should be found in multiple sclerosis patients in Africa and Asia, and the
indigenous peoples in America, Australia, and New Zealand. Reich and colleagues
(2005) noted that the tendency for multiple sclerosis to affect Europeans more frequently
than Africans provided the opportunity to search for susceptibility genes by conducting
an admixture linkage analysis. They hypothesized that African-American individuals
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with multiple sclerosis would be expected to have a disproportionately greater degree of
European ancestry in those regions of the genome encoding multiple sclerosis
susceptibility genes, and they were able to implicate a novel susceptibility locus on
chromosome 1. The fact that linkage in this region among European families is
nonexistent suggests that the responsible variant is likely to have a very high background
frequency in Europeans. This novel finding appears to explain the long-established
excess risk seen in the European population and urgently requires replication and
refinement (Reich et al. 2005).
Defining the minimal European chromosomal components shared among multiple
sclerosis patients could be an effective approach to a comprehensive isolation of the
susceptibility alleles for the disease. Determining and detecting the minimal European
chromosomal components may be an accurate and reliable method for predicting the risk
for developing multiple sclerosis at birth or early in life. It is possible that with early
detection of these chromosome components, multiple sclerosis could be prevented, since
the susceptibility alleles may have low penetrance, and because the onset of the disease
occurs primarily in later life.
The results of this analysis may help to study other diseases that display
substantial racial and ethnic differences in incidence. It is known that, compared to other
races and ethnicities, Europeans are more susceptible to multiple forms of malignancies
(Weinstein et al. 2002). Some of these malignancies, including breast cancer, lung
cancer, and brain tumors, are known to be associated with genetic factors (Ahlbom et al.
1997). A study similar to the current one has been conducted with respect to prostate
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cancer. Likewise, studies investigating the correlation between Scandinavian migration
and settlement history and cancer incidence could be conducted.
Currently, the etiology of multiple sclerosis is unknown. Although inheritance
primarily plays the determining role of whether an individual will develop the disease,
other risk factors may have an immense effect on development. The current project
adapted a reductionistic approach to address the importance of inheritance, in isolation
from other contributing factors. The congruous geographic distribution between the
European migration and settlement history and global multiple sclerosis prevalence is
unlikely to be a coincidence. Identification of the minimal European chromosome
components shared in multiple sclerosis patients in other racial and ethnic groups should
confirm the results of this analysis.
A novel strategy to identify the etiology of multiple sclerosis was used in this
study. The international prevalence data for multiple sclerosis in respect to racial and
ethnic constituents of nations worldwide, together with the global migratory history of
racial and ethnical groups was examined, and this study revealed a previously
unrecognized aspect of multiple sclerosis epidemiology: high prevalence of multiple
sclerosis in certain regions is associated with migration and settlement history of certain
human races. This finding suggests that there is an inherited susceptibility to multiple
sclerosis, which has been transmitted by admixture to different racial and ethnic groups.

Limitations of this analysis
There were several major limitations to this research project. First, the tabulated
data from MSIF and literature sources were incomplete. Data were collected from a
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variety of sources, but none of these sources had data from each country and some of the
data were outdated, meaning the data were greater than 10 years old. The most common
reason for missing data is that it simply did not exist within the countries in question,
specifically in African nations. Second, the data used in this project were obtained from
secondary sources. All data were obtained from publications and websites dedicated to
researching the epidemiology and etiology of diseases such as multiple sclerosis. Some
of these data sources had differing incidence and prevalence rates for the same country.
In such cases, registry data were used over sample data, or the more reliable of the two
rates was used (see Methods and Procedures). Third, much of the data used in the current
project were obtained from the Multiple Sclerosis International Federation, which
collected data primarily from voluntary sector sources. The Federation stated that a
limitation to its own data collection methodology was that information regarding the
public and private sectors may have been incomplete and may not have been completely
generalizable or representative of the actual figures for the country in question.
Furthermore, both incidence and prevalence data were used in this analysis since
prevalence data were not available for every country. Out of the 77 countries examined,
prevalence data were used in 64 of them, with few prevalence rates accordingly noted.
Using both incidence and prevalence data could have possibly skewed the results of this
analysis. In future studies, it would be best to use only incidence or only prevalence data
for each nation so that a baseline rate can be established.
To resolve some of these limitations, it would be helpful for just one foundation,
perhaps the MSIF or National Multiple Sclerosis Society to take responsibility for
keeping an updated, cohesive record of global multiple sclerosis incidence and
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prevalence rates. If one foundation could take responsibility for keeping the record up to
date and accurate, it would resolve the issues of figure differences between groups and
outdated information. It would also be helpful to establish a registry of multiple sclerosis
cases in Africa, where there currently is no such registry and thus prevalence data for the
disease are difficult to find.
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